2012
DOI: 10.1183/09031936.00015612
|View full text |Cite
|
Sign up to set email alerts
|

Cell cycle dependence of ACE-2 explains downregulation in idiopathic pulmonary fibrosis

Abstract: Alveolar epithelial type II cells, a major source of angiotensin-converting enzyme (ACE)-2 in the adult lung, are normally quiescent but actively proliferate in lung fibrosis and downregulate this protective enzyme. It was, therefore, hypothesised that ACE-2 expression might be related to cell cycle progression.To test this hypothesis, ACE-2 mRNA levels, protein levels and enzymatic activity were examined in fibrotic human lungs and in the alveolar epithelial cell lines A549 and MLE-12 studied at postconfluent… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
51
0
1

Year Published

2013
2013
2024
2024

Publication Types

Select...
7

Relationship

1
6

Authors

Journals

citations
Cited by 62 publications
(53 citation statements)
references
References 41 publications
(65 reference statements)
1
51
0
1
Order By: Relevance
“…2B, complete inhibition of cathepsin D enzymatic activity by pepstatin A supports the specificity of the enzyme assay for aspartyl protease induction by MG132. Figure 3 shows that ER stress induced by MG132 also downregulated the ANGII-degrading enzyme ACE-2, beginning at a concentration of 7.5 M. ACE-2 was also downregulated by the alternate proteasome inhibitor CLBL if applied to A549 cells cultured at a higher cell density, suggesting that the downregulation was due to proteasome inhibition rather than density-dependent effects on cell proliferation (21). In agreement with that interpretation, the G100S BRICHOS domain mutant of SP-C, when transfected into A549 cells alongside wild-type SP-C in the same plasmid, also reduced ACE-2, especially the low molecular weight (MW) active form of the enzyme.…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…2B, complete inhibition of cathepsin D enzymatic activity by pepstatin A supports the specificity of the enzyme assay for aspartyl protease induction by MG132. Figure 3 shows that ER stress induced by MG132 also downregulated the ANGII-degrading enzyme ACE-2, beginning at a concentration of 7.5 M. ACE-2 was also downregulated by the alternate proteasome inhibitor CLBL if applied to A549 cells cultured at a higher cell density, suggesting that the downregulation was due to proteasome inhibition rather than density-dependent effects on cell proliferation (21). In agreement with that interpretation, the G100S BRICHOS domain mutant of SP-C, when transfected into A549 cells alongside wild-type SP-C in the same plasmid, also reduced ACE-2, especially the low molecular weight (MW) active form of the enzyme.…”
Section: Resultsmentioning
confidence: 99%
“…3) each downregulated ACE-2 and did so at two different cell densities, each cultured in the absence of growth factors (serumfree medium). Moreover, the proteasome inhibition caused by these agents is known to inhibit, not stimulate, the cell proliferation that downregulated ACE-2 in the absence of these agents (21). For this reason, it is suggested here that ER stress constitutes another mechanism responsible for the downregulation of ACE-2 in fibrotic human lung.…”
Section: L38 Angiotensin 1-7 Abrogates Apoptosis Induced By Er Stressmentioning
confidence: 87%
See 1 more Smart Citation
“…11A). It is well known that ACE2 expression is cell cycle dependent and is very sensitive to the cell confluence levels [10]. To exclude the influence of cell confluence, we performed the experiment in controlled 50-70% cell confluence.…”
Section: Resultsmentioning
confidence: 99%
“…ACE2 activity and expression level were reported to be severely down regulated or absent in proliferating alveolar epithelial cell lines A549 and MLE-12, while its activity and expression level went much higher in quiescent A549 and MLE-12 cells [10]. Loss of ACE2 in mice enhanced the expression of genes that were induced by hypoxia and elevated mice serum Ang Ⅱ, causing endothelial dysfunction, vasoconstriction and cardiac hypoperfusion [11, 12].…”
Section: Introductionmentioning
confidence: 99%